Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qixiao Granules
- Development stage
- Unknown
- Lead developer
- Hospital Affiliated to Changchun University of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qixiao Granules (七效颗粒) is a traditional Chinese medicine (TCM) botanical formulation developed by the Affiliated Hospital of Changchun University of Chinese Medicine. It is primarily investigated for the treatment of mild to moderate active ulcerative colitis, specifically targeting patients presenting with TCM syndromes of spleen deficiency with dampness or mixed cold-heat. The drug is administered orally as a granule formulation. Clinical development has reached Phase II in China, where studies focus on evaluating its efficacy in improving clinical symptoms and promoting mucosal healing in patients with inflammatory bowel disease. As a multi-component herbal preparation, it is intended to regulate gastrointestinal function and modulate inflammatory responses in the colonic mucosa.
- Other names
- Qixiao Keli七效颗粒
Beyond the preview
Go deeper on Qixiao Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qixiao Granules.